Skip to main content
. 2009 May 5;587(Pt 13):3271–3285. doi: 10.1113/jphysiol.2009.169771

Figure 7. Nitric oxide (NO) component of EDD (NO bioavailability) in carotid arteries from (A) young (Y) cage control (CC), (B) old (O) CC, (C) Y voluntary wheel running (VR) and (D) OVR mice in response to ACh alone (CNT) or after pre-treatment with TEMPOL or apocynin (APO) (n= 6–10 per group).

Figure 7

NO bioavailability (%) = Maximum DilatationACh+L−NAME– Maximum DilatationACh. *P < 0.05 vs. matched CNT.